Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer

Research output: Contribution to journalArticle

13 Scopus citations

Fingerprint Dive into the research topics of 'Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences